The CRISP2 Polyclonal Antibody (CAB7177) is a valuable tool for researchers studying CRISP2, a protein involved in sperm function and male fertility. This antibody, generated in rabbits, shows high reactivity with human samples and is validated for use in various applications such as Western blot and immunohistochemistry.CRISP2, also known as cysteine-rich secretory protein 2, is predominantly expressed in the testis and has been implicated in sperm-egg fusion and fertilization processes. Studies have shown that CRISP2 plays a crucial role in male reproductive health and infertility. By targeting and detecting CRISP2 protein, researchers can gain insights into its function and potential implications in fertility-related disorders.
The CRISP2 Polyclonal Antibody is a valuable tool for researchers seeking to explore the role of CRISP2 in male fertility and reproductive health. Its specificity and reliability make it an ideal choice for studies investigating the molecular mechanisms underlying sperm function and fertilization processes. Further research into CRISP2 using this antibody could lead to the development of novel diagnostic and therapeutic strategies for male infertility.
Product Name:
CRISP2 Rabbit Polyclonal Antibody
SKU:
CAB7177
Size:
20uL, 100uL
Isotype:
IgG
Host Species:
Rabbit
Reactivity:
Mouse,Rat
Immunogen:
Recombinant fusion protein containing a sequence corresponding to amino acids 22-243 of human CRISP2 (NP_003287.1).
Predicted to be involved in cell-cell adhesion. Predicted to be active in extracellular space.
Purification Method:
Affinity purification
Gene ID:
7180
Storage Buffer:
Store at -20℃. Avoid freeze / thaw cycles.Buffer: PBS with 0.02% sodium azide,50% glycerol,pH7.3.
Western blot analysis of extracts of various cell lines, using CRISP2 antibody (CAB7177) at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (CABS014) at 1:10000 dilution.Lysates/proteins: 25μg per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Enhanced Kit (AbGn00021).Exposure time: 5s.
